L-K6

General Information


DRACP ID  DRACP00775

Peptide Name   L-K6

Sequence  IKKILSKIKKLLK

Sequence Length  13

UniProt ID  Not available

PubChem CID  Not available

Origin  some cationic antimicrobial peptides

Type  Synthetic peptide

Classification

  

Active ACP



Activity Information


Cell Line Disease Cancer Classified Activity Assay Testing Time Literature
MCF-7 Invasive breast carcinoma of no special type Carcinoma IC50=38 μM MTT assay 1h 1
MCF-7 Invasive breast carcinoma of no special type Carcinoma IC50=34 μM MTT assay 6h 1
MCF-7 Invasive breast carcinoma of no special type Carcinoma IC50=31 μM MTT assay 24h 1
MCF-7 Invasive breast carcinoma of no special type Carcinoma IC50=23 μM MTT assay 48h 1

Hemolytic Activity  Rabbit red blood cells: modest hemolytic activity(as show in Fig.2)

Normal (non-cancerous) Cytotoxicity  HUVEC: IC50=65.88±4.5 μM

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer; Antitumor



Structure Information


PDB ID  Not available

Predicted Structure  DRACP00775

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C75H145N19O15

Absent amino acids  ACDEFGHMNPQRTVWY

Common amino acids  K

Mass  176733

Pl  11.5

Basic residues  6

Acidic residues  0

Hydrophobic residues  6

Net charge  6

Boman Index  -718

Hydrophobicity  5.38

Aliphatic Index  180

Half Life 
  Mammalian: 2.8 hour
  Yeast: 3 min
  E.coli: 2 min

Extinction Coefficient cystines  0

Absorbance 280nm  0

Polar residues  1

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 28811617

Title  Cell surface binding, uptaking and anticancer activity of L-K6, a lysine/leucine-rich peptide, on human breast cancer MCF-7 cells

Doi 10.1038/s41598-017-08963-2

Year  2017

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DRACP is developed by Dr.Zheng's team.